SEATTLE CANCER CARE ALLIANCE — History
CCN 500138 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$1.2B
Latest Revenue (FY2022)
+14.7%
Revenue CAGR (3yr)
-68.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $890M | $1.0B | $1.2B | +15.8% | +14.7% |
| Operating Expenses | $841M | $1.0B | $2.0B | +88.6% | +53.3% |
| Operating Margin | 5.6% | -3.6% | -68.6% | -1825.5% | +0.0% |
| Net Income | $49M | $-36M | $-804M | -2130.2% | +0.0% |
| Licensed Beds | 20 | 20 | 20 | +0.0% | +0.0% |
| Total Patient Days | 6,268 | 6,353 | 6,827 | +7.5% | +4.4% |
| Medicare Day % | 21% | 24% | 22% | -8.1% | +3.4% |
| Medicaid Day % | 2% | 4% | 3% | -26.6% | +9.4% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +31.6% ($890M → $1.2B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+14.7%
This Hospital
+7.6%
State Avg
Latest Margin
-68.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $1.3B | -105.7% |
| FY2024 (proj) | $1.5B | -142.8% |
| FY2025 (proj) | $1.6B | -179.9% |